ConductScience.org, home

Gene · 64072

Papers1,428

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 1,428

Download this page as JSON
TitleJournalYearPMIDFound bySource
GelMA/PEDOT:PSS Composite Conductive Hydrogel-Based Generation and Protection of Cochlear Hair Cells through Multiple Signaling Pathways.Biomolecules202438254695PubTator, text miningPubMed
Interactions of genetic variations in FAS, GJB2 and PTPRN2 are associated with noise-induced hearing loss: a case-control study in China.BMC Med Genomics202438212800PubTator, text miningPubMed
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.Ther Adv Hematol202438186638PubTator, text miningPubMed
Novel compound heterozygous MYO15A splicing variants in autosomal recessive non-syndromic hearing loss.BMC Med Genomics202438167320PubTator, text miningPubMed
Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells.Stem Cell Res Ther202438167128PubTator, text miningPubMed
Using the Bayesian variational spike and slab model in a genome-wide association study for finding associated loci with bipolar disorder.Ann Hum Genet202438161273PubTator, text miningPubMed
The RRAS2 pathogenic variant (c.67G>T; p. Gly23Cys) produces Noonan syndrome with embryonal rhabdomyosarcoma.Mol Genet Genomic Med202437942564PubTator, text miningPubMed
Whole-genome resequencing reveals new mutations in candidate genes for Beichuan-white goat prolificacya.Anim Biotechnol202437729465PubTator, text miningPubMed
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer.Genes Dis202437692501PubTator, text miningPubMed
Pediatric Macrocorticotropinoma: Do They Differ from Microcorticotropinoma?Neuroendocrinology202437634509PubTator, text miningPubMed
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma.Front Endocrinol (Lausanne)202338152133PubTator, text miningPubMed
Identification of a novel compound heterozygous pathogenic variant in MYO7A causing Usher syndrome type IB in a Chinese patient: a case report.J Int Med Res202338141656PubTator, text miningPubMed
Random Allelic Expression in Inherited Retinal Disease Genes.Curr Issues Mol Biol202338132471PubTator, text miningPubMed
Treatment following Triple-AAV Delivery in Mature Murine Model of Human CDH23-Associated Hearing Loss.Curr Issues Mol Biol202338132436PubTator, text miningPubMed
Which Came First? When Usher Syndrome Type 1 Couples with Neuropsychiatric Disorders.Audiol Res202338131811PubTator, text miningPubMed
Quantitative thresholds for variant enrichment in 13,845 cases: improving pathogenicity classification in genetic hearing loss.Genome Med202338111038PubTator, text miningPubMed
Traditional Chinese medicine for the prevention and treatment of presbycusis.Heliyon202338076135PubTator, text miningPubMed
The Relevance of Autophagy within Inner Ear in Baseline Conditions and Tinnitus-Related Syndromes.Int J Mol Sci202338068993PubTator, text miningPubMed
Accurate phenotypic classification and exome sequencing allow identification of novel genes and variants associated with adult-onset hearing loss.PLoS Genet202338011198PubTator, text miningPubMed
Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.Cancer Cell Int202338008721PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/64072/papers?page=6